# Larazotide for celiac symptoms despite a gluten-free diet

Source: https://pepvault.app/research/larazotide-leffler-2015

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Larazotide](https://pepvault.app/research#larazotide)

Randomized trial · people

# Larazotide: 0.5 mg arm eased celiac symptoms on gluten-free diet

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In one mid-stage trial, only the lowest larazotide dose eased celiac symptoms beyond a gluten-free diet alone, and the higher doses showed no benefit.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 342
- **Published:** 2015
- **Journal:** Gastroenterology

## What they tested

The team tested whether larazotide acetate could ease ongoing celiac disease symptoms in adults who still had them while staying on a gluten-free diet.

## How the study was done

A multicenter, randomized, double-blind, placebo-controlled phase II trial in 342 adults with celiac disease who had kept a gluten-free diet for 12 months or longer. They took 0.5, 1, or 2 mg 3 times daily or placebo (a dummy treatment) for 12 weeks, with 4 weeks on placebo before and 4 weeks on placebo after.

<!--promo-->

PepVault for iPhone

## Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The 0.5 mg arm met the main goal, with fewer gut symptoms than placebo on the Celiac Disease Gastrointestinal Symptom Rating Scale. On exploratory measures, the 0.5 mg arm had 26% fewer symptomatic days, 31% more improved symptom days, more people with abdominal pain cut by 50% or more for 6 or more of the 12 weeks, and less headache and tiredness. The 1 mg and 2 mg arms did no better than placebo on any measure. Safety was similar to placebo.

## What it doesn’t show

This was a 12-week phase II trial, and only the lowest dose beat placebo while the higher doses did not, so the results were mixed. Most of the extra benefits came from exploratory measures, not the main goal.

## The paper

Leffler et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology. 2015.

- [PubMed (PMID 25683116)](https://pubmed.ncbi.nlm.nih.gov/25683116/)
- [The paper (DOI 10.1053/j.gastro.2015.02.008)](https://doi.org/10.1053/j.gastro.2015.02.008)
- [ClinicalTrials.gov (NCT01396213)](https://clinicaltrials.gov/study/NCT01396213)

## The compound

- [Larazotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

## With this study

### Larazotide

- [Larazotide: the full reference](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

### Studies

- [Larazotide: eased GI symptoms in celiac patients on gluten challenge](https://pepvault.app/research/larazotide-hoilat-2022)
- [Larazotide sped gut symptom recovery in children with post-COVID MISC](https://pepvault.app/research/larazotide-yonker-2025)
- [All 6 studies](https://pepvault.app/research#larazotide)

### Compared with

- [BPC-157 vs Larazotide](https://pepvault.app/peptides/compare/bpc-157-vs-larazotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

## More studies on Larazotide

- [Larazotide: eased GI symptoms in celiac patients on gluten challenge](https://pepvault.app/research/larazotide-hoilat-2022) Meta-analysis · people · 2022
- [Larazotide sped gut symptom recovery in children with post-COVID MISC](https://pepvault.app/research/larazotide-yonker-2025) Randomized trial · people · 2025
- [Larazotide: no gut permeability rise after gluten in celiac patients](https://pepvault.app/research/larazotide-paterson-2007) Randomized trial · people · 2007
- [Larazotide lowered gut leakage in rats with acute pancreatitis](https://pepvault.app/research/larazotide-karahan-2024) Animal study · rats · 2024
- [Larazotide aided tight junction assembly in MDCK and Caco-2 cells](https://pepvault.app/research/larazotide-gopalakrishnan-2012) Cell study · MDCK and Caco-2 cells · 2012
- [Every study on Larazotide](https://pepvault.app/research#larazotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Larazotide

- [Larazotide: the full reference](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

### Studies

- [Larazotide: eased GI symptoms in celiac patients on gluten challenge](https://pepvault.app/research/larazotide-hoilat-2022)
- [Larazotide sped gut symptom recovery in children with post-COVID MISC](https://pepvault.app/research/larazotide-yonker-2025)
- [All 6 studies](https://pepvault.app/research#larazotide)

### Compared with

- [BPC-157 vs Larazotide](https://pepvault.app/peptides/compare/bpc-157-vs-larazotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Larazotide](https://pepvault.app/research#larazotide)

## The library

- [Larazotide](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
